Parker Financial LLC Abb Vie Inc. Transaction History

Parker Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$154.79 - $180.76 $7,584 - $8,857	49 Added 3.56%	1,424 $244 Million
Q1 2024 Apr 22, 2024	SELL	$159.82 - $182.1 $19,338 - $22,034	-121 Reduced 8.09%	1,375 $250 Million
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $275 - $309	2 Added 0.13%	1,496 $232 Million
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $133,590 - $154,650	-1,000 Reduced 40.1%	1,494 $223 Million
Q2 2023 Jul 20, 2023	BUY	$132.51 - $164.9 $330,479 - $411,260	2,494 New	2,494 $336 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $186,165 - $223,261	1,346 New	1,346 $218 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Parker Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Parker Financial LLC with notifications on news.